These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 18462811

  • 1. Serotonin transporter is differentially localized in subpopulations of lymphocytes of major depression patients. Effect of fluoxetine on proliferation.
    Fazzino F, Montes C, Urbina M, Carreira I, Lima L.
    J Neuroimmunol; 2008 May 30; 196(1-2):173-80. PubMed ID: 18462811
    [Abstract] [Full Text] [Related]

  • 2. Serotonin, 5-HT1A serotonin receptors and proliferation of lymphocytes in major depression patients.
    González A, Fazzino F, Castillo M, Mata S, Lima L.
    Neuroimmunomodulation; 2007 May 30; 14(1):8-15. PubMed ID: 17700035
    [Abstract] [Full Text] [Related]

  • 3. Effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients.
    Peña S, Baccichet E, Urbina M, Carreira I, Lima L.
    Int Immunopharmacol; 2005 Jun 30; 5(6):1069-76. PubMed ID: 15829422
    [Abstract] [Full Text] [Related]

  • 4. Noradrenaline transporter and its turnover rate are decreased in blood lymphocytes of patients with major depression.
    Mata S, Urbina M, Manzano E, Ortiz T, Lima L.
    J Neuroimmunol; 2005 Dec 30; 170(1-2):134-40. PubMed ID: 16242784
    [Abstract] [Full Text] [Related]

  • 5. Effects of venlafaxine and fluoxetine on lymphocyte subsets in patients with major depressive disorder: a flow cytometric analysis.
    Başterzi AD, Yazici K, Buturak V, Cimen B, Yazici A, Eskandari G, Tot Acar S, Taşdelen B.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb 01; 34(1):70-5. PubMed ID: 19804808
    [Abstract] [Full Text] [Related]

  • 6. Fluoxetine directly counteracts the adverse effects of chronic stress on T cell immunity by compensatory and specific mechanisms.
    Frick LR, Rapanelli M, Cremaschi GA, Genaro AM.
    Brain Behav Immun; 2009 Jan 01; 23(1):36-40. PubMed ID: 18625298
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HPA axis activation in major depression and response to fluoxetine: a pilot study.
    Young EA, Altemus M, Lopez JF, Kocsis JH, Schatzberg AF, DeBattista C, Zubieta JK.
    Psychoneuroendocrinology; 2004 Oct 01; 29(9):1198-204. PubMed ID: 15219644
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Can serotonin and fluoxetine levels in plasma and platelets predict clinical response in depression?
    Castrogiovanni P, Blardi P, De Lalla A, Dell'Erba A, Auteri A.
    Psychopharmacol Bull; 2003 Oct 01; 37(2):102-8. PubMed ID: 14566218
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder.
    Papakostas GI, McGrath P, Stewart J, Charles D, Chen Y, Mischoulon D, Dording C, Fava M.
    Psychiatry Res; 2008 Oct 30; 161(1):116-20. PubMed ID: 18755514
    [Abstract] [Full Text] [Related]

  • 18. Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding.
    Sugimoto Y, Kajiwara Y, Hirano K, Yamada S, Tagawa N, Kobayashi Y, Hotta Y, Yamada J.
    Eur J Pharmacol; 2008 Sep 11; 592(1-3):116-22. PubMed ID: 18655786
    [Abstract] [Full Text] [Related]

  • 19. Plasma catecholamine levels after fluoxetine treatment in depressive patients.
    Blardi P, de Lalla A, Auteri A, Iapichino S, Dell'Erba A, Castrogiovanni P.
    Neuropsychobiology; 2005 Sep 11; 51(2):72-6. PubMed ID: 15741747
    [Abstract] [Full Text] [Related]

  • 20. Kynurenine metabolites and inflammation markers in depressed patients treated with fluoxetine or counselling.
    Mackay GM, Forrest CM, Christofides J, Bridel MA, Mitchell S, Cowlard R, Stone TW, Darlington LG.
    Clin Exp Pharmacol Physiol; 2009 Apr 11; 36(4):425-35. PubMed ID: 19018805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.